Carboxamidine derivatives and their use in the treatment of vascular diseases

Details for Australian Patent Application No. 2003202104 (hide)

Owner Cytrx Corporation

Inventors Jegesne Csakai, Zita; Urogdi, Laszlo; Denes, Laszlo; Marvanyos, Ede; Bathone Torok, Magdolna

Agent Shelston IP

Pub. Number AU-B-2003202104

PCT Number PCT/HU03/00003

PCT Pub. Number WO2003/057664

Priority P 0204362 17.12.02 HU; P 0200109 11.01.02 HU

Filing date 10 January 2003

Wipo publication date 24 July 2003

Acceptance publication date 18 September 2008

International Classifications

C07D 295/08 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61K 31/45 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide

A61K 31/4545 (2006.01)

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61K 31/5395 (2006.01) - having two or more nitrogen atoms in the same ring, e.g. oxadiazines

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

C07C 259/02 (2006.01) Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups

C07D 213/89 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 295/088 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 295/22 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): P 0204362 17.12.02 HU; P 0200109 11.01.02 HU

4 September 2003 Application Open to Public Inspection

  Published as AU-B-2003202104

23 November 2006 Change of Name(s) of Applicant(s), Section 104

  Biorex Kutato es Fejileszto The name of the applicant has been changed to CytRx Corporation

18 September 2008 Application Accepted

  Published as AU-B-2003202104

2 October 2008 Corrigenda

  Applications Accepted - Name Index Under the Name Cytrx Corporation, Application No. 2003202104, under INID (71), correct the name of the applicant to CytRx Corporation

22 January 2009 Standard Patent Sealed

4 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003202105-METHOD FOR OBTAINING AN ANTITUMOR SUBSTANCE FROM EVENTOE HOOFED MAMMALS

2003202103-MULTI-TARGET SCREENING